Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

I am no expert but am trying to see the bigger pic

Message Board Public Reply | Private Reply | Keep | Replies (4)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153768
(Total Views: 1076)
Posted On: 08/08/2020 10:11:58 PM
Posted By: thriftycents
Re: generactor #47972
I am no expert but am trying to see the bigger picture. Given that NP has said that our day 3 score is better than the placebo one assumption we can make is that leronlimab is working quickly (this fits with the 72 hour recovery we have heard from Dr. Jay, Dr. BP as well as testimonials). However, due to the fact that many m2m patients recover on their own (especially if you happen to get more "mild" patients in the placebo arm) we may not see statistical significance at days 7 or 14.

One might than conclude that we are helping patients get better quicker but that some m2m patients would very well recover on their own by days 7 and 14.

All of this has been said. What I am really curious to see are these "Other Outcome Measures"

Quote:
Other Outcome Measures:
Change in size of lesion area by chest radiograph or CT [ Time Frame: Day 14 ]
Change from baseline in serum cytokine and chemokine levels [ Time Frame: Days 3, 7, and 14 ]
Change from baseline in CCR5 receptor occupancy levels for Tregs and macrophages [ Time Frame: Days 3, 7, and 14 ]
Change from baseline in CD3+, CD4+ and CD8+ T cell count [ Time Frame: Days 3, 7, and 14 ]



If these show corresponding improvements that bolster that narrative than haven't we in effect nailed it? I actually think this trial is quite clever in this regard. First, you are effectively validating Dr. Patterson's proposed theory on the pathogenesis of COVID. Second, you can correlate a patients recovery with those immunological markers. And third, you may even be able to show that although a patient has recovered clinically at day 7 or 14, they may not have fully recovered immunilogically (i.e. long haulers or people who experience strange systems after leaving the hospital).

The reason I bring this up is because I was mistakenly focusing mainly on primary/secondary endpoints. I think these "other outcome measures" are very important in the m2m case.

Personally, I think a solid PR on the results would really tie these all together nicely and paint a picture of how the disease works as well as how leronlimab is clearly speeding the recovery process. I wish they could utilize graphs as Dr. Patterson did in his paper and show that although placebo patients recovered, they did so more slowly as evidenced by these immunological markers. Furthermore, if patients didn't recovery fully immunologically (even though clinically they may have) it would be fascinating to point that out as that begs for a "long hauler" trial.



(16)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us